Federal Supply Schedule 36F79725D0238
Award Date 9/29/25
Last Date to Order 9/28/30
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Pricing Type
Fixed Price with Economic Price Adjustment
Legislative Mandate
Not listed National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed Similar IDVs
- Agios Pharmaceuticals, Inc. (UEI: KKWAB4MN58M3) was awarded a Federal Supply Schedule contract under the Pharmaceuticals and Drugs (FSS-61-IB) master schedule by the Veterans Integrated Service Network 12, a civilian agency within the Department of Veterans Affairs. This multiple-award contract, issued on February 15, 2019, with a ceiling value of $225,000.00 and completion date of September 14, 2026, establishes Agios as a supplier of drugs, pharmaceuticals, and hematology-related products. The...
- Kowa Pharmaceuticals America Inc. (UEI: MKFCR1R78GD3) was awarded a multiple-award Federal Supply Schedule contract under the Pharmaceuticals and Drugs (FSS-61-IB) master schedule on April 1, 2023, for the provision of drugs, pharmaceuticals, and hematology-related products. This civilian contract, funded by the Veterans Integrated Service Network 12 (VISN 12), carries a ceiling value of $174,737,620 and extends through March 31, 2028. The contract operates under General Services...
- This Federal Supply Schedule contract awards Intrabio Inc. (UEI: ZGRFJJWUPGJ2) a $225,000 ceiling value multiple-award blanket purchase agreement under the General Services Administration's Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). The contract was awarded on July 1, 2025, with an ultimate completion date of June 30, 2030, representing a five-year performance period. The contract encompasses Category 65 I B products, specifically drugs, pharmaceuticals, and...
- Ionis Pharmaceuticals, Inc. was awarded a Federal Supply Schedule contract under General Services Administration Schedule 65 I B for Drugs, Pharmaceuticals, & Hematology Related Products by Veterans Integrated Service Network 12 (VISN 12), a civilian component of the Department of Veterans Affairs. This multiple-award indefinite delivery vehicle carries a ceiling value of $225,000.00 with a performance period extending from August 15, 2025, through August 14, 2030. No set-asides were...
- Kamada Inc. (UEI: RHMCCBAFTZ95) was awarded a multiple-award Federal Supply Schedule contract under the Pharmaceuticals and Drugs (FSS-61-IB) master schedule on July 1, 2024, with a contract ceiling value of $750,000 and an ultimate completion date of June 30, 2029. The contract was awarded by the Veterans Integrated Service Network 12, a civilian component of the Department of Veterans Affairs, with no set-aside restrictions applied. Under this indefinite delivery vehicle, Kamada Inc. will...
- This Federal Supply Schedule contract awards multiple indefinite delivery vehicles to Medicure Pharma Inc. (UEI: KC1ZK4GF2SX9) for the procurement of drugs, pharmaceuticals, and hematology-related products under General Services Administration Schedule 61-IB (Pharmaceuticals and Drugs). The contract was awarded on September 29, 2023, with an ultimate completion date of September 28, 2028, establishing a five-year period of performance. The contract carries a ceiling value of $7,454,790.00 and...
- This Federal Supply Schedule contract, awarded to Thea Pharma, Inc. (UEI: KD52SC8KRMW5) on February 1, 2023, establishes a multiple-award indefinite delivery vehicle for the procurement of pharmaceuticals, drugs, and hematology-related products under General Services Administration Schedule 61-IB. The contract is funded through the Veterans Integrated Service Network 12, a civilian agency within the Department of Veterans Affairs responsible for delivering healthcare services to veterans...
- This Federal Supply Schedule contract awards multiple indefinite delivery vehicle positions to Aadi Bioscience, Inc. (UEI: FUGDEGHGZ583) under the General Services Administration's Pharmaceuticals and Drugs schedule (FSS-61-IB), specifically under Federal Supply Classification 65 I B for drugs, pharmaceuticals, and hematology-related products. The contract was awarded on August 1, 2022, with an ultimate completion date of July 31, 2027, establishing a five-year period of performance. The...
- This Federal Supply Schedule contract awards Provepharm Inc. (UEI: RQC5M6BKFYK8) a multiple award agreement to provide drugs, pharmaceuticals, and hematology-related products under General Services Administration Federal Supply Schedule 61-IB (Pharmaceuticals and Drugs). The contract was awarded on March 15, 2023, with a ceiling value of $225,000 and an ultimate completion date of March 14, 2028, representing a five-year period of performance. The Veterans Integrated Service Network 12, a...
- This Federal Supply Schedule contract awards Aveo Pharmaceuticals, Inc. (doing business as Aveo Oncology) a multiple-award indefinite delivery vehicle for the supply of drugs, pharmaceuticals, and hematology-related products under General Services Administration (GSA) schedule 61-IB. The contract was awarded on October 15, 2021, with an ultimate completion date of October 14, 2026, and carries a ceiling value of $45.58 million. The funding agency is the Veterans Integrated Service Network (VISN)...